Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Investor Growth Capital via Venture Partners and InnKap in connection with the acquisition of Projectplace International AB
Mandate

Vinge advises Investor Growth Capital via Venture Partners and InnKap in connection with the acquisition of Projectplace International AB

June 30, 2009

Vinge has advised Investor Growth Capital via Venture Partners and InnKap in connection with the acquisition of Projectplace International AB. The company develops and supplies Europe’s leading Internet-based project tools in seven different language versions. The project tools facilitate and increase efficiency in the day-to-day project work of thousands of users in over 20,000 projects worldwide. In 2008, the company’s turnover amounted to SEK 129 million.

Vinge’s team advising the purchasers consisted of responsible partner Johan Winnerblad together with associates Per Larsson and Christoffer Benninge.

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

 On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

 SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026